Current Opinion in Lipidology
- Is it time to reconcile HDL with cardiovascular diseases and beyond? An update on a paradigm shift
- Measurement of carotid plaque burden
- The interplay between serum amyloid A and HDLs
- Atherosclerosis: cell biology and lipoproteins
- Transport of LDLs into the arterial wall: impact in atherosclerosis
- Fibroblasts in atherosclerosis: heterogeneous and plastic participants
- Age-associated arterial calcification: the current pursuit of aggravating and mitigating factors
- Editorial introductions
- Emerging insight into the role of cellular cholesterol in the pathogenesis of nonalcoholic steatohepatitis progression
- The potential role of the lipid phosphate phosphatase 3 (Plpp3) gene in cardiovascular disease
- Dietary patterns to promote healthy aging
- When to lower triglycerides?
- Metabolic and cardiovascular outcomes of bariatric surgery
- Dietary treatment to lower cholesterol and triglyceride and reduce cardiovascular risk
- Genetic, biochemical, and clinical features of LCAT deficiency: update for 2020
- Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism
- Epigenetics of paraoxonases
- Can genetic testing help in the management of dyslipidaemias?
- Small interfering RNA to proprotein convertase subtilisin/kexin type 9: transforming LDL-cholesterol-lowering strategies
- Evidence for improved survival with treatment of homozygous familial hypercholesterolemia